17-beta-hydroxysteroid dehydrogenase deficiency screening

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Molecular Genetic Studies
Genotyping
X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
17-beta-hydroxysteroid dehydrogenase deficiency screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency screening
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency screening
17-beta-hydroxysteroid dehydrogenase deficiency screening in the news
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency screening
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

• There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.

Screening

• There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.